Cagdas Baran

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

1. Introduction Although advances have been made in the diagnosis, therapy, and development of new oral anticoagulants, acute pulmonary embolism (aPE) and its complications remain common, with high mortality and morbidity rates. The global burden of acute pulmonary embolism has remained significant, with high incidence rates worldwide despite these advancements.

1. Introduction Postcardiotomy shock occurs when patients remain at low output after cardiac surgery, and it has a high mortality rate. Postcardiotomy shock is a severe complication following cardiac surgery, characterized by persistent low cardiac output despite maximal medical therapy. Mechanical circulatory support using veno-arterial extracorporeal membrane oxygenation (VA-ECMO) and intra-aortic balloon pump (IABP) are established treatments for this condition.